0001209191-15-056868.txt : 20150626 0001209191-15-056868.hdr.sgml : 20150626 20150626171446 ACCESSION NUMBER: 0001209191-15-056868 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150625 FILED AS OF DATE: 20150626 DATE AS OF CHANGE: 20150626 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KEMPHARM, INC CENTRAL INDEX KEY: 0001434647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205894398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2656 CROSSPARK ROAD, SUITE 100 CITY: CORALVILLE STATE: IA ZIP: 52241 BUSINESS PHONE: 319-665-2575 MAIL ADDRESS: STREET 1: 2656 CROSSPARK ROAD, SUITE 100 CITY: CORALVILLE STATE: IA ZIP: 52241 FORMER COMPANY: FORMER CONFORMED NAME: KEMPHARM INC DATE OF NAME CHANGE: 20080507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson Gordon K CENTRAL INDEX KEY: 0001638367 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36913 FILM NUMBER: 15956002 MAIL ADDRESS: STREET 1: 2656 CROSSPARK ROAD STREET 2: SUITE 100 CITY: CORALVILLE STATE: IA ZIP: 52241 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-06-25 0 0001434647 KEMPHARM, INC KMPH 0001638367 Johnson Gordon K C/O KEMPHARM, INC. 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 0 1 0 0 Chief Business Officer Stock Option (right to buy) 18.29 2015-06-25 4 A 0 160000 0.00 A 2025-06-24 Common Stock 160000 160000 D Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 25% of the total shares subject to the option vest in equal annual installments beginning on June 25, 2016 through June 25, 2019, provided, that in the event that the Company terminates the Reporting Person's employment without Cause or for Good Reason three (3) months prior to or within twelve (12) months following a Change in Control (as defined in the Plan), then the option shall become fully vested and immediately exercisable as of such date. The option expires ten years after the date of grant. /s/ Matthew P. Dubofsky, Attorney-in-Fact 2015-06-26